… tests before starting the implicated drug should be obtained if possible. Data on the duration
of drug therapy is crucial to evaluate the time to onset of the drug reaction. An important part …

… to determine in patients with established coronary heart disease whether the Joint European
Societies' recommendations on coronary prevention are being followed in clinical practice. …

… associated with drug metabolism include CYP1A2, CYP2C9, and CYP2D6. Drug therapy
interacts … Drugs that inhibit CYP450 enzymes generally lead to decreased metabolism of other …

… therapy or may lead to complications among patients whose treatment is already underway.
We therefore review the clinical … (BUP) and antiretroviral therapies and provide an approach …

… therapy, including the optimal dose of aspirin, the variable balance of benefits and hazards in
… clinical settings, and the issue of interindividual variability in response to antiplatelet drugs. …

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th
Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your …

… challenging clinical scenarios, such as lack of therapeutic response, relapse, or adverse
drug … clinical practice in order to help optimize the efficacy and safety of those antipsychotics. …

… drug therapy at the end of life are discussed, including principles of decision making about
drug treatments, specific aspects of drug therapy … choice and use of drugs to treat symptoms in …

… However, in clinical practice, multiple variables impinge on the enzyme or receptor targets
of a given patient, thereby frequently causing large interpatient, as well as intrapatient, …

… on the clinical and public health management of tuberculosis in children and adults in
settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and …